Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Lapointe

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Critical Reviews in Oncology/Hematology|August 28, 2022
Integrating hereditary breast and ovarian cancer genetic counselling and testing into mainstream clinical practice: Legal and ethical challengesMarilou Charron, Beatrice Kaiser, Aurélie Dauge, et al.
Journal of Personalized Medicine|September 28, 2021
Identifying Clinicopathological Factors Associated with Oncotype DX<sup>®</sup> 21-Gene Recurrence Score: A Real-World Retrospective Cohort Study of Breast Cancer Patients in Quebec City, CanadaSimon Gagnet, Caroline Diorio, Louise Provencher, et al.
BMJ Open|December 16, 2022
Examining interprofessional collaboration in oncogenetic service delivery models for hereditary cancers: a scoping review protocolMaria Eugenia Espinoza Moya, Jason Robert Guertin, Michel Dorval, et al.
Journal of Clinical Medicine Research|March 1, 2014
Lack of Clinical Benefit of Thromboprophylaxis in Patients Hospitalized in a Medical Unit Over a 10-year SpanGabrielle Migner-Laurin, Thomas St-Aubin, Julie Lapointe, et al.
Cornea|June 10, 2015
Evolution of Corneal Transplantation in the Province of Quebec From 2000 to 2011Marie-Claude Robert, Marie-Eve Choronzey, Julie Lapointe, et al.
Critical Reviews in Oncology/Hematology|May 10, 2024
Mapping inter-professional collaboration in oncogenetics: Results from a scoping reviewMaria-Eugenia Espinoza-Moya, Jason Robert Guertin, Arthur Floret, et al.
Pilot and Feasibility Studies|July 14, 2025
A community pharmacy-based program to enhance adherence to adjuvant endocrine therapy among breast cancer survivors (PACHA): protocol for a pilot cluster-randomized controlled trialJulie Lapointe, Laurence Guillaumie, Anne Dionne, et al.
Healthcare (Basel, Switzerland)|September 28, 2021
Cross-Cultural Adaptation and Validation of a French Version of the Genetic Counseling Satisfaction Scale (GCSS) as an Outcome Measure of Genetic Counseling for Hereditary Breast and Ovarian CancerCélia Villafane-Bernier, Julie Lapointe, Camille Raîche, et al.
Journal of Genetic Counseling|October 27, 2024
Cross-cultural adaptation and validation of a French version of the perceived personal control questionnaire as an outcome measure instrument for genetic counselingCamille Raîche, Julie Lapointe, Célia Villafane-Bernier, et al.
BMJ Open|February 17, 2025
Feasibility and acceptability of a personalised primary prevention strategy for women and men at high risk of breast and prostate cancer: the 3PC study protocol for a pilot randomised controlled trialIntissar Souli, Julie Lapointe, Jura Kinsley-Marlie, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Critical Reviews in Oncology/Hematology|August 28, 2022
Integrating hereditary breast and ovarian cancer genetic counselling and testing into mainstream clinical practice: Legal and ethical challengesMarilou Charron, Beatrice Kaiser, Aurélie Dauge, et al.
Journal of Personalized Medicine|September 28, 2021
Identifying Clinicopathological Factors Associated with Oncotype DX<sup>®</sup> 21-Gene Recurrence Score: A Real-World Retrospective Cohort Study of Breast Cancer Patients in Quebec City, CanadaSimon Gagnet, Caroline Diorio, Louise Provencher, et al.
BMJ Open|December 16, 2022
Examining interprofessional collaboration in oncogenetic service delivery models for hereditary cancers: a scoping review protocolMaria Eugenia Espinoza Moya, Jason Robert Guertin, Michel Dorval, et al.
Journal of Clinical Medicine Research|March 1, 2014
Lack of Clinical Benefit of Thromboprophylaxis in Patients Hospitalized in a Medical Unit Over a 10-year SpanGabrielle Migner-Laurin, Thomas St-Aubin, Julie Lapointe, et al.
Cornea|June 10, 2015
Evolution of Corneal Transplantation in the Province of Quebec From 2000 to 2011Marie-Claude Robert, Marie-Eve Choronzey, Julie Lapointe, et al.
Critical Reviews in Oncology/Hematology|May 10, 2024
Mapping inter-professional collaboration in oncogenetics: Results from a scoping reviewMaria-Eugenia Espinoza-Moya, Jason Robert Guertin, Arthur Floret, et al.
Pilot and Feasibility Studies|July 14, 2025
A community pharmacy-based program to enhance adherence to adjuvant endocrine therapy among breast cancer survivors (PACHA): protocol for a pilot cluster-randomized controlled trialJulie Lapointe, Laurence Guillaumie, Anne Dionne, et al.
Healthcare (Basel, Switzerland)|September 28, 2021
Cross-Cultural Adaptation and Validation of a French Version of the Genetic Counseling Satisfaction Scale (GCSS) as an Outcome Measure of Genetic Counseling for Hereditary Breast and Ovarian CancerCélia Villafane-Bernier, Julie Lapointe, Camille Raîche, et al.
Journal of Genetic Counseling|October 27, 2024
Cross-cultural adaptation and validation of a French version of the perceived personal control questionnaire as an outcome measure instrument for genetic counselingCamille Raîche, Julie Lapointe, Célia Villafane-Bernier, et al.
BMJ Open|February 17, 2025
Feasibility and acceptability of a personalised primary prevention strategy for women and men at high risk of breast and prostate cancer: the 3PC study protocol for a pilot randomised controlled trialIntissar Souli, Julie Lapointe, Jura Kinsley-Marlie, et al.
Pageof 3